 |
인쇄하기
취소
|
Ilyang presents updated phase II clinical results for Supect at 2012 ASH annual meeting
Ilyang and its collaborators Monday provided phase II clinical presentations on Supect (radotinib) at the annual meeting of the American Society of Hematology (ASH), which held on Atlanta between December 8 and 12.
The clinical results, which was presented by professor Kim Sung-hyun of Dong-A University Hospital, showed that Supect, a newly-developed drug for chronic myelogenous leukemia (CL...
The clinical results, which was presented by professor Kim Sung-hyun of Dong-A University Hospital, showed that Supect, a newly-developed drug for chronic myelogenous leukemia (CL...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.